chr2-120955454-G-A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001374353.1(GLI2):​c.643+24G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.918 in 1,495,488 control chromosomes in the GnomAD database, including 642,611 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.79 ( 52062 hom., cov: 33)
Exomes 𝑓: 0.93 ( 590549 hom. )

Consequence

GLI2
NM_001374353.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.372

Publications

8 publications found
Variant links:
Genes affected
GLI2 (HGNC:4318): (GLI family zinc finger 2) This gene encodes a protein which belongs to the C2H2-type zinc finger protein subclass of the Gli family. Members of this subclass are characterized as transcription factors which bind DNA through zinc finger motifs. These motifs contain conserved H-C links. Gli family zinc finger proteins are mediators of Sonic hedgehog (Shh) signaling and they are implicated as potent oncogenes in the embryonal carcinoma cell. The protein encoded by this gene localizes to the cytoplasm and activates patched Drosophila homolog (PTCH) gene expression. It is also thought to play a role during embryogenesis. The encoded protein is associated with several phenotypes- Greig cephalopolysyndactyly syndrome, Pallister-Hall syndrome, preaxial polydactyly type IV, postaxial polydactyly types A1 and B. [provided by RefSeq, Jul 2008]
GLI2 Gene-Disease associations (from GenCC):
  • holoprosencephaly 9
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Illumina, Ambry Genetics
  • combined pituitary hormone deficiencies, genetic form
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • holoprosencephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.84).
BP6
Variant 2-120955454-G-A is Benign according to our data. Variant chr2-120955454-G-A is described in ClinVar as Benign. ClinVar VariationId is 259732.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.976 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLI2NM_001374353.1 linkc.643+24G>A intron_variant Intron 5 of 13 ENST00000361492.9 NP_001361282.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLI2ENST00000361492.9 linkc.643+24G>A intron_variant Intron 5 of 13 1 NM_001374353.1 ENSP00000354586.5 A0A7I2PJA1

Frequencies

GnomAD3 genomes
AF:
0.788
AC:
119845
AN:
152094
Hom.:
52059
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.380
Gnomad AMI
AF:
0.995
Gnomad AMR
AF:
0.886
Gnomad ASJ
AF:
0.886
Gnomad EAS
AF:
0.999
Gnomad SAS
AF:
0.956
Gnomad FIN
AF:
0.979
Gnomad MID
AF:
0.867
Gnomad NFE
AF:
0.947
Gnomad OTH
AF:
0.840
GnomAD2 exomes
AF:
0.916
AC:
166619
AN:
181970
AF XY:
0.925
show subpopulations
Gnomad AFR exome
AF:
0.372
Gnomad AMR exome
AF:
0.937
Gnomad ASJ exome
AF:
0.885
Gnomad EAS exome
AF:
1.00
Gnomad FIN exome
AF:
0.974
Gnomad NFE exome
AF:
0.948
Gnomad OTH exome
AF:
0.922
GnomAD4 exome
AF:
0.933
AC:
1253332
AN:
1343276
Hom.:
590549
Cov.:
20
AF XY:
0.935
AC XY:
623114
AN XY:
666244
show subpopulations
African (AFR)
AF:
0.350
AC:
10631
AN:
30380
American (AMR)
AF:
0.930
AC:
33837
AN:
36366
Ashkenazi Jewish (ASJ)
AF:
0.890
AC:
20700
AN:
23266
East Asian (EAS)
AF:
1.00
AC:
37691
AN:
37700
South Asian (SAS)
AF:
0.954
AC:
74580
AN:
78194
European-Finnish (FIN)
AF:
0.974
AC:
48182
AN:
49466
Middle Eastern (MID)
AF:
0.896
AC:
4852
AN:
5418
European-Non Finnish (NFE)
AF:
0.947
AC:
972419
AN:
1026778
Other (OTH)
AF:
0.905
AC:
50440
AN:
55708
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
3418
6836
10254
13672
17090
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19856
39712
59568
79424
99280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.788
AC:
119872
AN:
152212
Hom.:
52062
Cov.:
33
AF XY:
0.795
AC XY:
59148
AN XY:
74424
show subpopulations
African (AFR)
AF:
0.380
AC:
15770
AN:
41512
American (AMR)
AF:
0.886
AC:
13557
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.886
AC:
3077
AN:
3472
East Asian (EAS)
AF:
0.999
AC:
5133
AN:
5140
South Asian (SAS)
AF:
0.957
AC:
4622
AN:
4830
European-Finnish (FIN)
AF:
0.979
AC:
10399
AN:
10624
Middle Eastern (MID)
AF:
0.867
AC:
255
AN:
294
European-Non Finnish (NFE)
AF:
0.946
AC:
64375
AN:
68016
Other (OTH)
AF:
0.841
AC:
1777
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
806
1612
2419
3225
4031
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
830
1660
2490
3320
4150
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.713
Hom.:
12477
Bravo
AF:
0.762
Asia WGS
AF:
0.933
AC:
3243
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Holoprosencephaly 9 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.84
CADD
Benign
5.1
DANN
Benign
0.50
PhyloP100
0.37
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs12614482; hg19: chr2-121713030; API